Europe news

EMVO have issued the next EMVS Community Newsletter – March 2022. The Newsletter aims to inform about the Alert Management System, best practices on reducing alerts from the point of view of the Romanian NMVO.

European Commission (EC) has published a new version of the Questions & Answers document on “Safety Features for Medicinal Products for Human Use (V.19)”.

The European Commission has taken decision to extend the transitional period for a period of three years, which was determined in the context of the action of the medicine verification system regarding the medicine products exported to the United Kingdom* (UK) following its’ withdrew from the European Union.

Lai pārliecinātos, vai pašreizējais gala lietotāja izmantotais IT risinājums ir gatavs sistēmas izmaiņām, LZVO aicina laicīgi sazināties ar savu IT pakalpojumu sniedzēju.

In 2021 the Latvian Medicines Verification System has been operating stably, constantly ensuring the verification of medicines that are available to the Latvian population through legal supply chains, according to the annual report 2021 of the Latvian Medicines Verification Organization.

LZVO 2. martā organizēja semināru saviem partneriem – IT piegādātājiem, lai informētu viņus par sistēmas attīstību un citām aktualitātēm.

The customer satisfaction survey conducted by the Latvian Medicines Verification Organization (LZVO) received a high evaluation for its customer service.

Latvijas Zāļu verifikācijas organizācijas (LZVO) veiktajā gala lietotāju aptaujā par klientu servisu saņemts augsts novērtējums.

Last year residents of Latvia received only safe prescription medicine, checked at the end of legal supply chain – pharmacies and healthcare institutions. More than 26.2 million of packages have been verified for the authenticity by the medicine verification system.